MEI Pharma, Inc.
MEIP
$2.05
$0.010.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 75.80% | -114.20% | -83.53% | 40.88% | -207.90% |
| Total Depreciation and Amortization | -100.00% | 322.99% | 27.55% | -11.34% | -7.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -148.70% | -88.03% | 1,798.50% | -40.72% | 80.32% |
| Change in Net Operating Assets | 70.04% | 94.85% | -506.24% | 253.04% | 94.84% |
| Cash from Operations | 66.84% | 38.08% | -59.25% | 75.86% | 22.53% |
| Capital Expenditure | -- | -- | 100.00% | -- | -111.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.60% | 196.29% | 0.55% | -98.78% | 134.50% |
| Cash from Investing | -16.58% | 196.49% | 0.76% | -98.78% | 132.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 831.58% | 123.99% | -83.48% | -33.30% | 148.23% |